Therapeutic effect of CY-fTBI and BMM conditioning regimen in the process of allo-HSCT treatingⅢ,Ⅳnon-Hodgkin lymphoma:15 years analysis of single-center
Ting Sun,Liangding Hu,Min Jiang,Hongmei Ning,Bin Zhang,Jing Ren,Yuhang Li,Botao Li,Jianlin Chen,Fan Yang,Chen Xu,Jun Wang,Xiao Lou,Jiangwei Hu,Hu Chen
DOI: https://doi.org/10.3760/cma.j.issn.0253-2727.2015.10.005
2015-01-01
Abstract:Objective To investigate the efficacy of allogeneic hematopoietic stem cell transplantation(allo-HSCT)in the treatment of patients withⅢ,Ⅳnon-Hodgkin lymphoma(NHL), and compared the efficacy between Cy-fractionated to talbody irradiation(fTBI)based conditioning regimen and Maryland, horse flange and mitoxantrone(BMM). Methods The clinical data of 47 patients withⅢ, Ⅳ NHL after allo-HSCT from November 1998 to May 2014 were collected and retrospectively analyzed. To observe the hematopoietic reconstruction recovery after transplantation, cumulative incidence of acute graft- versus- host- disease (aGVHD) and chronic graft- versus- host- disease (cGVHD), transplantation related mortality (TRM), recurrence rate (RR), disease-free survival (DFS), overall survival(OS). Compare the efficacy of fTBI and BMM conditioning regimen at the same time. Results Neutrophils achieving 0.5 × 109/L and platelets achieving 50 × 109/L on day 17 (range, 10-72) post transplantation. Acute GVHD occurred in 53.19%, among them, grade Ⅰ-Ⅱ occurred in 42.55%, gradeⅢ-Ⅳoccurred in 10.65%, and cGVHD occurred in 21.28%. 21 patients were alive with a median follow up of 9.7 months(0.2-149.1 months). Overall survival(OS)was 73.5%, 49.3%, 40.1%respectively in the first, third and fifth year in Cy-fTBI group;in BMM group it was 67.8%, 32.9%and 31.4%respectively, and disease-free survival(DFS)was 65.3%, 45.6%, 30.2%respectively in the first, third and fifth year. In Cy-fTBI group, the recurrence rate(RR)and transplantation related mortality(TRM)in the first year were 18.9%, 23.0% respectively, the third year were 19.5%, 38.3% and the fifth year were 35.2%, 39.2%. In BMM group, RR and TRM in the first year were 27.4%, 24.5% respectively, the third year were 38.9%, 46.4%and the fifth year were 39.2%, 48.2%. However, there was no significant difference in the indicator of OS, DFS, RR, TRM in the two groups. Conclusion Allo-HSCT could make someⅢ,ⅣNHL patients achieve long-term disease-free survival, but the TRM was still high relatively. Moreover, compared with the program of BMM conditioning regimen, Cy-fTBI might reduce the TRM and RR, meanwhile, increase the DFS and OS. However, due to the small number cases of two groups, there was no statistical significant difference.